← All Anteris Technologies Global CORP filings

Anteris Technologies Global CORP S-1 registration statements

Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.

NASDAQ
AVR
Anteris Technologies Global CORP
S-1: Anteris Technologies Registers 9.1M Shares for Resale
Anteris Technologies Global Corp. filed an S-1 registration statement for the resale of up to 9.1 million common shares by selling stockholders, following a recent private placement and warrant issuance.
NASDAQ
AVR
Anteris Technologies Global CORP
S-1/A: Anteris Technologies Global Corp. Files for U.S. IPO to Advance Heart Valve Technology
Anteris Technologies Global Corp., a structural heart company, has filed for an initial public offering (IPO) in the U.S. to support the development and commercialization of its innovative DurAVR transcatheter heart valve system.
NASDAQ
AVR
Anteris Technologies Global CORP
S-1: Anteris Technologies Global Corp. Files for U.S. IPO to Advance Heart Valve Technology
Anteris Technologies Global Corp., a structural heart company, has filed for an initial public offering (IPO) in the U.S. to support the development and commercialization of its innovative DurAVR transcatheter heart valve system.